Cite
HARVARD Citation
Mahtani, R. et al. (2022). Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel. Breast. pp. 236-244. [Online].